Robot maker · registered
Remedy Robotics
Endovascular robotic system (Remedy N1) combining proprietary hardware with AI-enabled software for remote and autonomous cardiovascular and neurointerventional procedures; controls up to 4 instruments simultaneously (wires, microcatheters, stents, coils, and proprietary 360-degree steerable catheters); portable console deployable onsite or at a remote site; integrated connectivity management with CT/MRI-to-fluoroscopy preprocessing; world's first fully remote cerebral angiograms and neurointerventional procedures completed September 2025 at Unity Health Toronto network; 45 patents on N1 System and software; not yet cleared for commercial sale as of mid-2026.
Company overview
Identity and operating footprint
Robot models
Specifications remain vendor-claimed
Remedy N1 System
- Controls up to 4 endovascular tools simultaneously; supports proprietary 360-degree steerable catheters plus off-the-shelf wires, microcatheters, stents, and coils; integrates into any catheterization lab; portable operator console; 45 patents
vendor-stated functional capabilities of the Remedy N1 endovascular robotic system at public unveil (October 2025)
Claim source
Deployment log
Announced and cited only
Funding history
Publicly announced rounds
Series A
DCVC, Blackbird Ventures, Pathbreaker Ventures, KdT Ventures, Build Collective
Round sourceHiring signal
Public job board · 2026-07-13
Hiring is an operating signal, not deployment evidence. Roles are refreshed from the company’s public careers system.
Company timeline
Milestones and announcements
Source ledger
8 unique public sources